GSK2636771
GSK2636771 is a potent, selective, and orally bioavailable inhibitor of PI3Kβ. It is used in research for studying various cancers, including lymphoma and solid tumors, and has been evaluated in both in vitro assays and in vivo xenograft models for advanced malignancies.
Product Specifications
CAS Number
1372540-25-4
Product Name Alternative
Phosphoinositide 3-kinase, PI3K, PI3Kβ, inhibit, Inhibitor, GSK2636771, GSK-2636771, GSK 2636771
Field of Research
Signal Transduction
Purity
>98%
Form
Powder
Solubility
Soluble in DMSO (up to 20 mg/ml)
Smiles
Cc1nc2c (cc (cc2n1Cc1cccc (c1C) C (F) (F) F) N1CCOCC1) C (O) =O
Molecular Formula
C22H22F3N3O3
Molecular Weight
433.4
Storage Conditions
-20°C
Notes
For research use only.
Other Product Names
2-Methyl-1- (2-methyl-3- (trifluoromethyl) benzyl) -6-morpholino-1H-benzo[d]imidazole-4-carboxylic acid
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
PROTP42831-5ug 5 µg
Swine recombinant CCL2 (C-C Motif Chemokine Ligand 2) protein, AF
Sign In for Pricing
View Details 
